Medexus Pharmaceuticals Inc (MDP) NPV
Sell:2.96 CADBuy:3.04 CAD
0.03 CAD
(0.99%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:2.96 CAD
Buy:3.04 CAD
Change:0.03 CAD
(0.99%)
0.03 CAD
(0.99%)Prices delayed by at least 15 minutes
Sell:2.96 CAD
Buy:3.04 CAD
Change:0.03 CAD
(0.99%)
0.03 CAD
(0.99%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 20 August 2025 | Stephen William NelsonIndependent Director | Buy Regular purchase transaction | 30,000 | 2.92 CAD | 87,561.00 CAD | 134,891 |
| 20 August 2025 | Richard LabelleCOO | Sell Option/Award related | 56,778 | 2.96 CAD | 168,062.88 CAD | 90,222 |
| 10 February 2025 | Brendon BuschmanCFO | Buy Regular purchase transaction | 5,000 | 3.07 CAD | 15,350.00 CAD | 83,311 |
| 7 February 2025 | Brendon BuschmanCFO | Buy Regular purchase transaction | 10,000 | 3.47 CAD | 34,700.00 CAD | 78,311 |
| 6 December 2024 | Michael Peter (Mike) MuellerChairman of the Board | Buy Regular purchase transaction | 3,500 | 2.89 CAD | 10,115.00 CAD | 4,500 |
| 6 December 2024 | Michael Peter (Mike) MuellerChairman of the Board | Sell Regular sell transaction (market) | 3,500 | 2.86 CAD | 10,010.00 CAD | 0 |
| 19 November 2024 | Richard LabelleCOO | Sell Option/Award related | 3,937 | 2.11 CAD | 8,307.07 CAD | 151,063 |
| 19 November 2024 | Kenneth D'EntremontChairman/CEO | Sell Option/Award related | 9,593 | 2.11 CAD | 20,241.23 CAD | 102,409 |
| 19 November 2024 | Brendon BuschmanCFO | Sell Option/Award related | 1,742 | 2.11 CAD | 3,675.62 CAD | 34,258 |
| 15 November 2024 | Ian Craig Wildgoose BrownCompany Secretary | Sell Option/Award related | 6,000 | 2.12 CAD | 12,720.00 CAD | 12,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 20 August 2025 | Richard LabelleCOO | Sell Option/Award related | 56,778 | 2.96 CAD | 168,062.88 CAD | 90,222 |
| 20 August 2025 | Stephen William NelsonIndependent Director | Buy Regular purchase transaction | 30,000 | 2.92 CAD | 87,561.00 CAD | 134,891 |
| 7 February 2025 | Brendon BuschmanCFO | Buy Regular purchase transaction | 10,000 | 3.47 CAD | 34,700.00 CAD | 78,311 |
| 19 November 2024 | Kenneth D'EntremontChairman/CEO | Sell Option/Award related | 9,593 | 2.11 CAD | 20,241.23 CAD | 102,409 |
| 26 September 2024 | Benoit GravelIndependent Director | Sell Tax related | 7,594 | 2.43 CAD | 18,453.42 CAD | 63,532 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.